A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

M. Bathon, Joan; W. Martin, Richard; Fleischmann, Roy; Tesser, John; Schiff, Michael; Keystone, Edward; C. Genovese, Mark; Chester Wasko, Mary; W. Moreland, Larry; L. Weaver, Arthur; A. Markenson, Joseph; Finck, Barbara

doi:10.1056/nejm200011303432201

Public

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

Published in New England Journal of Medicine • Nov 30, 2000

Authors:

Joan M. Bathon

Richard W. Martin

Roy Fleischmann

Abstract

BACKGROUND: Etanercept, which blocks the action of tumor necrosis factor, reduces disease activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease activity and preventing joint damage in patients with active early rheumatoid arthritis is unknown. METHODS: We tre...

Subject

Etanercept

Medicine

Rheumatoid arthritis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!